Base Editing of <i>HBG1</i> and <i>HBG2</i> Promoters for Sickle Cell Disease

Ashish O. Gupta

University of Minnesota, Minneapolis

Akshay Sharma

Haydar Frangoul

Sarah Cannon Research Institute at the Children’s Hospital at TriStar Centennial, Nashville

Julie Kanter

Markus Y. Mapara

Columbia University Medical Center, New York

Jignesh Dalal

Rainbow Babies and Children’s Hospital, Cleveland

Asif Alavi

Henry Ford Health System, Detroit

Jennifer J. Jaroscak

Medical University of South Carolina, Charleston

Ernesto Ayala

Mayo Clinic, Jacksonville, FL

John F. DiPersio

Department of Medicine, Washington University School of Medicine, St. Louis

Edward D. Ziga

University of Miami, Miami

Mary Eapen

Medical College of Wisconsin, Milwaukee

Stacey Rifkin-Zenenberg

Hackensack University Medical Center, Hackensack, NJ

Alex C. Minella

Beam Therapeutics, Cambridge, MA

Yinzhong Chen

Beam Therapeutics, Cambridge, MA

Sarah Chesler

Beam Therapeutics, Cambridge, MA

Srikanth Ambati

Beam Therapeutics, Cambridge, MA

Thomas S. Bowman

Beam Therapeutics, Cambridge, MA

Bahru Habtemariam

Beam Therapeutics, Cambridge, MA

Marcelyne Joseney-Antoine

Beam Therapeutics, Cambridge, MA

Priya S. Chockalingam

Beam Therapeutics, Cambridge, MA

Ling Lin

Department of Psychiatry and Behavioral Sciences, Center for Sleep Sciences and Medicine, Stanford University

Sunita Goyal

Beam Therapeutics, Cambridge, MA

Amy Simon

Beam Therapeutics, Cambridge, MA

Alexis A. Thompson

Children’s Hospital of Philadelphia, Philadelphia

Matthew M. Heeney

Dana–Farber/Boston Children’s Cancer and Blood Disorders Center, Boston